annual CFO:
-$274.90M-$114.30M(-71.17%)Summary
- As of today (September 16, 2025), SNDX annual cash flow from operations is -$274.90 million, with the most recent change of -$114.30 million (-71.17%) on December 31, 2024.
- During the last 3 years, SNDX annual CFO has fallen by -$304.03 million (-1043.68%).
- SNDX annual CFO is now -1043.68% below its all-time high of $29.13 million, reached on December 31, 2021.
Performance
SNDX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$87.80M+$7.37M(+7.74%)Summary
- As of today (September 16, 2025), SNDX quarterly cash flow from operations is -$87.80 million, with the most recent change of +$7.37 million (+7.74%) on June 30, 2025.
- Over the past year, SNDX quarterly CFO has dropped by -$16.15 million (-22.54%).
- SNDX quarterly CFO is now -187.18% below its all-time high of $100.71 million, reached on December 31, 2021.
Performance
SNDX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$302.67M-$16.15M(-5.64%)Summary
- As of today (September 16, 2025), SNDX TTM cash flow from operations is -$302.67 million, with the most recent change of -$16.15 million (-5.64%) on June 30, 2025.
- Over the past year, SNDX TTM CFO has dropped by -$61.47 million (-25.49%).
- SNDX TTM CFO is now -1138.99% below its all-time high of $29.13 million, reached on December 31, 2021.
Performance
SNDX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SNDX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -71.2% | -22.5% | -25.5% |
| 3 y3 years | -1043.7% | -117.8% | -4576.6% |
| 5 y5 years | -443.2% | -310.1% | -416.6% |
SNDX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1043.7% | at low | -283.5% | +7.7% | -4576.6% | at low |
| 5 y | 5-year | -1043.7% | at low | -187.2% | +7.7% | -1139.0% | at low |
| alltime | all time | -1043.7% | at low | -187.2% | +7.7% | -1139.0% | at low |
SNDX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$87.80M(-7.7%) | -$302.67M(+5.6%) |
| Mar 2025 | - | -$95.16M(+65.8%) | -$286.52M(+4.2%) |
| Dec 2024 | -$274.90M(+71.2%) | -$57.39M(-7.9%) | -$274.90M(+6.2%) |
| Sep 2024 | - | -$62.32M(-13.0%) | -$258.86M(+7.3%) |
| Jun 2024 | - | -$71.64M(-14.2%) | -$241.19M(+17.7%) |
| Mar 2024 | - | -$83.55M(+102.1%) | -$204.92M(+27.6%) |
| Dec 2023 | -$160.60M(+20.1%) | -$41.35M(-7.4%) | -$160.60M(+13.0%) |
| Sep 2023 | - | -$44.65M(+26.2%) | -$142.15M(+12.8%) |
| Jun 2023 | - | -$35.37M(-9.8%) | -$126.04M(-3.8%) |
| Mar 2023 | - | -$39.23M(+71.3%) | -$130.97M(-2.0%) |
| Dec 2022 | -$133.68M(-558.9%) | -$22.89M(-19.8%) | -$133.68M(+1227.2%) |
| Sep 2022 | - | -$28.54M(-29.2%) | -$10.07M(+55.6%) |
| Jun 2022 | - | -$40.31M(-3.9%) | -$6.47M(-166.1%) |
| Mar 2022 | - | -$41.93M(-141.6%) | $9.79M(-66.4%) |
| Dec 2021 | $29.13M(-140.9%) | $100.71M(-503.7%) | $29.13M(-133.4%) |
| Sep 2021 | - | -$24.94M(+3.7%) | -$87.21M(+8.3%) |
| Jun 2021 | - | -$24.05M(+6.4%) | -$80.56M(+3.4%) |
| Mar 2021 | - | -$22.59M(+44.5%) | -$77.92M(+9.4%) |
| Dec 2020 | -$71.26M(+40.8%) | -$15.63M(-14.6%) | -$71.26M(+4.2%) |
| Sep 2020 | - | -$18.30M(-14.5%) | -$68.36M(+16.7%) |
| Jun 2020 | - | -$21.41M(+34.4%) | -$58.59M(+17.9%) |
| Mar 2020 | - | -$15.93M(+25.1%) | -$49.71M(-1.8%) |
| Dec 2019 | -$50.61M | -$12.73M(+49.2%) | -$50.61M(-4.4%) |
| Sep 2019 | - | -$8.53M(-31.9%) | -$52.93M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$12.53M(-25.6%) | -$62.87M(-4.0%) |
| Mar 2019 | - | -$16.83M(+11.9%) | -$65.49M(-4.4%) |
| Dec 2018 | -$68.53M(+44.7%) | -$15.04M(-18.6%) | -$68.53M(+3.5%) |
| Sep 2018 | - | -$18.47M(+21.9%) | -$66.21M(+14.3%) |
| Jun 2018 | - | -$15.15M(-23.8%) | -$57.92M(+6.1%) |
| Mar 2018 | - | -$19.87M(+56.2%) | -$54.57M(+15.2%) |
| Dec 2017 | -$47.37M(+34.7%) | -$12.72M(+25.0%) | -$47.37M(+5.1%) |
| Sep 2017 | - | -$10.18M(-13.7%) | -$45.06M(-2.7%) |
| Jun 2017 | - | -$11.80M(-6.9%) | -$46.33M(+11.9%) |
| Mar 2017 | - | -$12.67M(+21.6%) | -$41.42M(+17.8%) |
| Dec 2016 | -$35.16M(+1348.0%) | -$10.42M(-9.0%) | -$35.16M(+42.1%) |
| Sep 2016 | - | -$11.45M(+66.2%) | -$24.74M(+86.1%) |
| Jun 2016 | - | -$6.89M(+7.6%) | -$13.29M(+107.6%) |
| Mar 2016 | - | -$6.40M(+146.1%) | -$6.40M(-53.2%) |
| Dec 2015 | -$2.43M(-83.1%) | - | - |
| Dec 2014 | -$14.39M(+97.3%) | - | - |
| Sep 2014 | - | -$2.60M(-31.6%) | -$13.67M(+3.6%) |
| Jun 2014 | - | -$3.80M(-15.7%) | -$13.20M(+40.5%) |
| Mar 2014 | - | -$4.51M(+63.7%) | -$9.39M(+47.5%) |
| Dec 2013 | -$7.29M(-21.4%) | -$2.76M(+29.6%) | -$6.37M(+76.3%) |
| Sep 2013 | - | -$2.13M(+43.2%) | -$3.61M(+143.2%) |
| Mar 2013 | - | -$1.49M | -$1.49M |
| Dec 2012 | -$9.28M(-7.4%) | - | - |
| Dec 2011 | -$10.02M | - | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual CFO year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly CFO year-on-year change?
- What is Syndax Pharmaceuticals, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. TTM CFO year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual cash flow from operations?
The current annual CFO of SNDX is -$274.90M
What is the all time high annual CFO for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual cash flow from operations is $29.13M
What is Syndax Pharmaceuticals, Inc. annual CFO year-on-year change?
Over the past year, SNDX annual cash flow from operations has changed by -$114.30M (-71.17%)
What is Syndax Pharmaceuticals, Inc. quarterly cash flow from operations?
The current quarterly CFO of SNDX is -$87.80M
What is the all time high quarterly CFO for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly cash flow from operations is $100.71M
What is Syndax Pharmaceuticals, Inc. quarterly CFO year-on-year change?
Over the past year, SNDX quarterly cash flow from operations has changed by -$16.15M (-22.54%)
What is Syndax Pharmaceuticals, Inc. TTM cash flow from operations?
The current TTM CFO of SNDX is -$302.67M
What is the all time high TTM CFO for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high TTM cash flow from operations is $29.13M
What is Syndax Pharmaceuticals, Inc. TTM CFO year-on-year change?
Over the past year, SNDX TTM cash flow from operations has changed by -$61.47M (-25.49%)